Divergent pathways for TNF and C2-ceramide toxicity in HTC hepatoma cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 7, 2009, Pages 1182-1190

  Autelli, Riccardo ^a   Ullio, Chiara ^a   Prigione, Elisa ^a   Crepaldi, Silvia ^a   Schiavone, Nicola ^b   Brunk, Ulf T ^c   Capaccioli, Sergio ^b   Baccino, Francesco M ^a   Bonelli, Gabriella ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Bcl xL protein; Cell death; Endo lysosomes; Hepatoma cells; TNF alpha

Indexed keywords

CERAMIDE; DESIPRAMINE; DEXAMETHASONE; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; GENE SILENCING; GENETIC TRANSFECTION; LIVER CELL CARCINOMA; LYSOSOME; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CARCINOMA, HEPATOCELLULAR; CERAMIDES; DEXAMETHASONE; GLUCOCORTICOIDS; LIVER NEOPLASMS, EXPERIMENTAL; LYSOSOMES; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 67649388045     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.03.005     Document Type: Article

References (30)

1. Hussain S.P., Schwank J., Staib F., Wang X.W., and Harris C.C. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26 (2007) 2166-2176
2. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., and Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17 (1998) 1675-1687
3. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev., Mol. Cell Biol. 2 (2001) 589-598
4. Evans-Storms R.B., and Cidlowski J.A. Dominant suppression of lymphocyte apoptosis by hepatoma cells. Exp. Cell Res. 230 (1997) 121-132
5. Autelli R., Crepaldi S., De Stefanis D., Parola M., Bonelli G., and Baccino F.M. Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells. Apoptosis 10 (2005) 777-786
6. Lockshin R.A., and Zakeri Z. Apoptosis, autophagy, and more. Int. J. Biochem. Cell Biol. 36 (2004) 2405-2419
7. Schneider-Brachert W., Tchikov V., Neumeyer J., Jakob M., Winoto-Morbach S., Held-Feindt J., Heinrich M., Merkel O., Ehrenschwender M., Adam D., Mentlein R., Kabelitz D., and Schutze S. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21 (2004) 415-428
8. Kagedal K., Zhao M., Svensson I., and Brunk U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359 (2001) 335-343
9. Morgenstern J.P., and Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18 (1990) 3587-3596
10. Yu Z., Persson H.L., Eaton J.W., and Brunk U.T. Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic. Biol. Med. 34 (2003) 1243-1252
11. L. Cell Death Differ. 14 (2007) 840-850
12. Jaattela M., Cande C., and Kroemer G. Lysosomes and mitochondria in the commitment to apoptosis: a potential role for cathepsin D and AIF. Cell Death Differ. 11 (2004) 135-136
13. Kurz T., Terman A., Gustafsson B., and Brunk U.T. Lysosomes and oxidative stress in aging and apoptosis. Biochim. Biophys. Acta 1780 (2008) 1291-1303
14. Segui B., Bezombes C., Uro-Coste E., Medin J.A., Andrieu-Abadie N., Auge N., Brouchet A., Laurent G., Salvayre R., Jaffrezou J.P., and Levade T. Stress-induced apoptosis is not mediated by endolysosomal ceramide. FASEB J. 14 (2000) 36-47
15. Zhang J., Alter N., Reed J.C., Borner C., Obeid L.M., and Hannun Y.A. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5325-5328
16. Pariante C.M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A.H., and Kerwin R.W. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br. J. Pharmacol. 134 (2001) 1335-1343
17. Kim Y.S., Morgan M.J., Choksi S., and Liu Z.G. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol. Cell 26 (2007) 675-687
18. Kroemer G., and Jaattela M. Lysosomes and autophagy in cell death control. Nat. Rev., Cancer 5 (2005) 886-897
19. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 8 (2001) 569-581
20. Stoka V., Turk V., and Turk B. Lysosomal cysteine cathepsins: signaling pathways in apoptosis. Biol. Chem. 388 (2007) 555-560
21. Pettus B.J., Chalfant C.E., and Hannun Y.A. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585 (2002) 114-125
22. Rath P.C., and Aggarwal B.B. TNF-induced signaling in apoptosis. J. Clin. Immunol. 19 (1999) 350-364
23. Hurwitz R., Ferlinz K., and Sandhoff K. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol. Chem. Hoppe-Seyler 375 (1994) 447-450
24. Honegger U.E., Roscher A.A., and Wiesmann U.N. Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. J. Pharmacol. Exp. Ther. 225 (1983) 436-441
25. Evans-Storms R.B., and Cidlowski J.A. Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaB. Endocrinology 141 (2000) 1854-1862
26. Petit P.X., Lecoeur H., Zorn E., Dauguet C., Mignotte B., and Gougeon M.L. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130 (1995) 157-167
27. Oh H.Y., Namkoong S., Lee S.J., Por E., Kim C.K., Billiar T.R., Han J.A., Ha K.S., Chung H.T., Kwon Y.G., Lee H., and Kim Y.M. Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP. Cell Death Differ. 13 (2006) 512-523
28. L induction. Cell Death Differ. 8 (2001) 279-288
29. L induction. Eur. J. Cancer 42 (2006) 3287-3293
30. L in human hepatocellular carcinomas. Hepatology 34 (2001) 55-61